Company intelligence / Profile preview

Greenfield BioVentures

Stamford, Connecticut, United Statesgreenfieldventures.com ↗

Ownership: Private
Development stage: Other

Overview

Greenfield BioVentures is an investment arm focused on accelerating value-inflection for promising early-stage therapeutic programs. It provides financing and operational support to companies and assets primarily at pre-clinical and early-human trial stages. The firm aims to reduce scientific risk and increase the probability of success for portfolio assets within 12–24 months post-investment.

Modalities: Small moleculesBiologics
Industry: Investors

Beyond the preview

Go deeper on Greenfield BioVentures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Greenfield BioVentures.

Explore the full profile